New Branded Patented Formulation Shown to Alleviate GLP-1 Medication-Induced Gut Issues
As originally reported on BusinessWire.com on November 4, 2024 PanTheryx® Introduces Relesium™—Groundbreaking All-Natural Ingredient Addresses Gastrointestinal Side Effects of Popular Weight-Loss Drugs BOULDER, CO—NOV. 4th—PanTheryx®, a global nutrition and biotechnology company, today announced the launch of Relesium™, a patented, all-natural supplement formulated to address pervasive gut-related side effects of glucagon-like peptide 1 (GLP-1) medications, including … Continued